Reimagining Weight Management with Digital Opinion Leaders, held between 27–28 January in Dubai. As the first summit of its ...
Novo Nordisk GBS aims to expand advanced research in India, enhancing its Bengaluru hub's role in global R&D and clinical ...
Tamer Mohamed, founder and CEO at Aspect Biosystems added: “Our partnership with Novo Nordisk combines more than a century of ...
Semaglutide is not the only medication in this drug class. Eli Lilly has developed its own GLP-1 receptor agonist, Tirzepatide, which edged out semaglutide in terms of weight loss in the recent ...
USD 609.51 billion; 2030 Projected Market Size: USD 960.37 billion; CAGR (2025–2030): 9.5%; Proteins & Protein Cr ...
According to MarketsandMarkets, the Proteins & Protein Crystals Market is projected to grow from about USD 609.51 billion in 2025 to USD 960.37 ...
For almost 60 years, scientists have tried to understand why DNA doesn't replicate wildly and uncontrollably every time a cell divides – which they ...
19hon MSN
Exclusive-Novo's Wegovy and Ozempic US advertising spend doubles rival Eli Lilly, data shows
By Harshita Mary Varghese and Patrick Wingrove Jan 28 (Reuters) - Novo Nordisk spent nearly $500 million on U.S. advertising ...
Jan 28 (Reuters) - U.S. retailer Walmart on Wednesday said it has elevated 3,000 pharmacy technician roles to operations team ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results